Table 1.
Clinical baseline characteristics of each patient.
| Patient | Age (y) | Height (cm) | BMI (kg/m2) | DW (kg) | PPB | Duration dialysis | Cause of ESRD | DM/nonDM | Protein (g/dl) | |
|---|---|---|---|---|---|---|---|---|---|---|
| A01 | 44 | 170 | 27.7 | 80.5 | SVC | 12–24 months | Atypical uremic hemolytic syndrome | non-DM | 6 | |
| A02 | 58 | 193 | 31.9 | 115,5 | SVC, CAA | 12–24 months | Diabetes type 2 | DM | 7.2 | |
| A05 | 83 | 180 | 20.4 | 67 | SVC | > 36 months | Nephrosclerosis, hypertension | non-DM | 6.4 | |
| A08 | 79 | 175 | 24.5 | 76.5 | SVC | 12–24 months | Diabetes type 2 | non-DM | 5.8 | |
| A09 | 43 | 191 | 24.4 | 81 | SVC, LAC | 12–24 months | Glomerulopathy, thin-basement syndrome | non-DM | n.d | |
| A12 | 64 | 176 | 22.6 | 71.5 | CAA, MGC | 24–36 months | Nephrosclerosis, hypertension | non-DM | 5.9 | |
| A13 | 77 | 182 | 26.0 | 86 | CAA, MGC | 36–48 months | Secondary, vascular, aortic aneurysm | non-DM | n.d | |
| A15 | 66 | 192 | 31.5 | 116 | SVC | > 48 months | Diabetes type 2 | non-DM | 7.1 | |
| A16 | 56 | 158 | 30.8 | 77 | SVC/CAA, MGC | 36–48 months | Interstitial nephritis | non-DM | n.d | |
| A17 | 80 | 167 | 21.9 | 60 | SVC | 36–48 months | Nephrosclerosis, hypertension | non-DM | 6.3 | |
| A19 | 76 | 159 | 24.5 | 59 | SVC | > 48 months | Nephrosclerosis, hypertension | non-DM | 5.9 | |
| Ca (mmol/l) | P (mmol/l) | iCa (mg/dl) | wPTH (pg/ml) | Hb (g/dl) | Fe (ug/dl) | TSAT (%) | Ferritin (ng/ml) | pH | HCO3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| A01 | 2.01 | 2.1 | 1.11 | 278 | 10.8 | 58 | 18.6 | 57.6 | 7.34 | 22.8 |
| A02 | 2.11 | 1.77 | 1.06 | 398.8 | 9.7 | 34.4 | 9.5 | 117.7* | 7.43 | 27.9 |
| A05 | 2.68 | 1.7 | 1.36 | 265.7 | 9.6 | 33.2 | 13.2 | 606.2 | 7.42 | 27.6 |
| A08 | 2.19 | 1.15 | 1.13 | 138.2 | 11.9 | 74.2 | 32.5 | 996.8 | 7.42 | 23.9 |
| A09 | 2.49 | 2.87 | n.d | 384 | 10.8 | 50.5 | 22 | 753 | n.d | n.d |
| A12 | 2.19 | 2.9 | 1.11 | 188.9 | 13.3 | 78.9 | 20 | 80 | 7.35 | 19.7 |
| A13 | 2.25 | 1.58 | n.d | n.d | 11.6 | 66.2 | 24 | 1171* | n.d | n.d |
| A15 | 2.32 | 1.33 | 1.11 | 150.8 | 10.4 | 98.5 | 31 | 584.1 | 7.35 | 19.7 |
| A16 | 2.24 | 2.08 | n.d | 649 | 11.1 | 66.8 | 36 | 954 | n.d | n.d |
| A17 | 1.94 | 1.39 | 0.99 | 194.9 | 9.0 | 33 | 14.5 | 481.4 | 7.41 | 20.8 |
| A19 | 1.98 | 1.77 | 1,04 | 228.5 | 10.8 | 68 | 26.1 | 354.5 | 7.32 | 23.9 |
BMI = body mass index, DW = dry weight on dialysis, ESRD = end-stage renal disease, PPD = primary phosphate binder (SVC = sevelamer carbonate, CAA = calcium acetate, LAC = lanthanum carbonate, MGC = magnesium carbonate), DM = diabetes mellitus, blood serum (or whole blood in case of pH & HCO3) values: P = phosphate, iCa = ionized calcium, Ca = total calcium, wPTH whole PTH, Hb = hemoglobin, Fe = iron, TSAT = transferrin saturation, HCO3 = bicarbonate (mmol/l); n.d. not determined; *patients on parenteral iron, possibly further increasing ferritin (A02, A13).